Doug is a C-suite executive with extensive experience translating scientific breakthroughs into marketed products that are at the center of building value for diagnostic and life science platform companies. His executive roles have included founding a diagnostic start-up company that was acquired by Clarient Inc, a national pathology reference lab subsequently acquired by GE Healthcare. He played a central role in the M&A transaction and integration that created an in vitro diagnostic test that grew into a $400M product for an international diagnostic platform company. Most recently, he has served on the executive leadership team at Oncocyte Inc, leading R&D and Medical Affairs through a turn-around phase, acquisition of three early stage
start-ups, and validation and launch of three proprietary products. He has led R&D organizations in new product invention, development, clinical maturation, and product launch and played integral roles in business development teams leading to multiple M&A transactions and team integrations. Doug holds an M.D. and Ph.D. in Pathology from the University of Washington School of Medicine, Fred Hutchinson Cancer Research Center.